PARP Inhibitors May Offer New Treatment Options for Cancer Patients
- Posted by ISPE Boston
- On December 12, 2018
PARP, or poly(ADP-ribose) polymerase, is a family of proteins that helps repair damaged DNA in cells. A PARP inhibitor may prevent cancer cells from repairing their damaged DNA, which can cause cancer cells to die. This may slow the return or progress of cancer. BRCA is a gene that is linked to increased risk for […]
Read More